TCMD vs. GMED

Last updated Apr 2, 2026

Compare and contrast key facts about Tactile Systems Technology, Inc. (TCMD) and Globus Medical, Inc. (GMED).

Performance

TCMD vs. GMED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tactile Systems Technology, Inc. (TCMD) and Globus Medical, Inc. (GMED). The values are adjusted to include any dividend payments, if applicable.

TCMD vs. GMED - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TCMD Tactile Systems Technology, Inc.	-10.45%	69.29%	19.79%	24.56%	-39.67%	-57.65%	-33.43%	48.21%	57.18%	76.60%
GMED Globus Medical, Inc.	0.49%	5.56%	55.21%	-28.25%	2.87%	10.70%	10.77%	36.04%	5.30%	65.66%

Fundamentals

Market Cap TCMD : $598.43M GMED : $11.98B
EPS TCMD : $0.83 GMED : $3.95
PE Ratio TCMD : 31.20 GMED : 22.21
PEG Ratio TCMD : 0.79 GMED : 0.23
PS Ratio TCMD : 1.81 GMED : 4.06
PB Ratio TCMD : 2.73 GMED : 2.62
Total Revenue (TTM) TCMD : $329.52M GMED : $2.94B
Gross Profit (TTM) TCMD : $223.91M GMED : $1.39B
EBITDA (TTM) TCMD : $36.52M GMED : $742.04M

Returns By Period

In the year-to-date period, TCMD achieves a -10.45% return, which is significantly lower than GMED's 0.49% return.

TCMD

• 1D: -0.61%
• 1M: -11.33%
• YTD: -10.45%
• 6M: 87.78%
• 1Y: 90.96%
• 3Y*: 16.51%
• 5Y*: -13.44%
• 10Y*: —

GMED

• 1D: 1.83%
• 1M: -6.46%
• YTD: 0.49%
• 6M: 49.57%
• 1Y: 19.55%
• 3Y*: 15.71%
• 5Y*: 7.24%
• 10Y*: 13.94%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TCMD vs. GMED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TCMD

TCMD Risk / Return Rank: 82
TCMD Sharpe Ratio Rank: 79
TCMD Sortino Ratio Rank: 82
TCMD Omega Ratio Rank: 89
TCMD Calmar Ratio Rank: 83
TCMD Martin Ratio Rank: 78

GMED

GMED Risk / Return Rank: 55
GMED Sharpe Ratio Rank: 54
GMED Sortino Ratio Rank: 54
GMED Omega Ratio Rank: 59
GMED Calmar Ratio Rank: 56
GMED Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TCMD vs. GMED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tactile Systems Technology, Inc. (TCMD) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TCMD	GMED	Difference
Sharpe ratio Return per unit of total volatility	1.29	0.37	+0.92
Sortino ratio Return per unit of downside risk	2.28	1.01	+1.27
Omega ratio Gain probability vs. loss probability	1.39	1.16	+0.23
Calmar ratio Return relative to maximum drawdown	2.73	0.64	+2.09
Martin ratio Return relative to average drawdown	5.58	1.20	+4.38
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TCMD vs. GMED - Sharpe Ratio Comparison

The current TCMD Sharpe Ratio is 1.29, which is higher than the GMED Sharpe Ratio of 0.37. The chart below compares the historical Sharpe Ratios of TCMD and GMED, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TCMD	GMED	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.29	0.37	+0.92
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.22	0.19	-0.42
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.40	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.42	-0.26

Correlation

The correlation between TCMD and GMED is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TCMD vs. GMED - Dividend Comparison

Neither TCMD nor GMED has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TCMD vs. GMED - Drawdown Comparison

The maximum TCMD drawdown since its inception was -91.41%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for TCMD and GMED.

Drawdown Indicators

	TCMD	GMED	Difference
Max Drawdown Largest peak-to-trough decline	-91.41%	-47.91%	-43.50%
Max Drawdown (1Y) Largest decline over 1 year	-35.39%	-31.27%	-4.12%
Max Drawdown (5Y) Largest decline over 5 years	-89.16%	-47.91%	-41.25%
Max Drawdown (10Y) Largest decline over 10 years	—	-47.91%	—
Current Drawdown Current decline from peak	-65.96%	-9.28%	-56.68%
Average Drawdown Average peak-to-trough decline	-49.02%	-15.38%	-33.64%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.29%	16.51%	+0.78%

Volatility

TCMD vs. GMED - Volatility Comparison

The current volatility for Tactile Systems Technology, Inc. (TCMD) is 7.12%, while Globus Medical, Inc. (GMED) has a volatility of 8.07%. This indicates that TCMD experiences smaller price fluctuations and is considered to be less risky than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TCMD	GMED	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.12%	8.07%	-0.95%
Volatility (6M) Calculated over the trailing 6-month period	48.81%	36.51%	+12.30%
Volatility (1Y) Calculated over the trailing 1-year period	71.19%	53.49%	+17.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	60.45%	37.45%	+23.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.80%	35.32%	+21.48%

Financials

TCMD vs. GMED - Profitability Comparison

The chart below illustrates the profitability comparison between Tactile Systems Technology, Inc. and Globus Medical, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

TCMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Tactile Systems Technology, Inc. reported a gross profit of 54.77M and revenue of 103.59M. Therefore, the gross margin over that period was 52.9%.

GMED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 826.42M. Therefore, the gross margin over that period was 0.0%.

TCMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Tactile Systems Technology, Inc. reported an operating income of 18.78M and revenue of 103.59M, resulting in an operating margin of 18.1%.

GMED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Globus Medical, Inc. reported an operating income of 171.70M and revenue of 826.42M, resulting in an operating margin of 20.8%.

TCMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Tactile Systems Technology, Inc. reported a net income of 10.63M and revenue of 103.59M, resulting in a net margin of 10.3%.

GMED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Globus Medical, Inc. reported a net income of 140.59M and revenue of 826.42M, resulting in a net margin of 17.0%.